OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Avobenzone 3% Sunscreen
Homosalate 10% Sunscreen
Octinoxate 7% Sunscreen
Octocrylene 5% Sunscreen
Active Ingredients Purpose
Avobenzone 3% Sunscreen
Homosalate 10% Sunscreen
Octinoxate 7% Sunscreen
Octocrylene 5% Sunscreen
Helps prevent Sunburn -If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Keep out of reach of children
Stop use and ask a doctor if rash occurs
Warnings
For External Use only
Do not use on damaged or broken Skin
When using this product keep out of eyes
Rinse with water to remove
If swallowed, get medical help or contact a poison control center right away
Directions Apply liberally at least 15 minutes prior to exposure to sun or UV lights
The perfect protection to keep in your purse or wherever your hands may be exposed to photoaging rays
Reapply at least every 2 hours
Use a water-resistant sunscreen if swimming or sweating
Children under 6 months Ask a doctor
Sun Protection Measures Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and take other sun protection measures including:
Limit time in the sun, especially from 10 a.m.- 2 p.m.
Wear long-sleeved shirts, pants, hats, and sunglasses
Argania Spinosa Kernel Oil, Caprylic/Capric Triglyceride, Cetearyl Alcohol, Cetyl Esters Chlorphenesin, Citral, Citrus Tangerina (Tangerine) Peel Oil, Cymbopogon Schoenanthus Oil, Diisopropyl Sebacate, Elettraria Cardamamomum Seed Oil, Eucalyptus Globulus Leaf Oil, Eugenia Caryophyllus (Clove) Flower Oil, Glycerin, Glyceryl Stearate, Glucose, Glucose Oxidase, Isodecyl Neopenatoate, Isododecane, Isolates, Lactoperoxidase, Lauryl Lactate, Lavandula Hybrida Oil, Limnanthes Alba (Meadowfoam) Seed Oil, Limonene, Magnesium Sulfate, Nylon-12, PEG-100 Stearate, Plantago Lanceolata Leaf Extract, Propanediol, Raphanus Sativus (Radish) Seed Oil, Sodium Hydroxide, Vanillin Natural, Water, Xanthan Gum.
Forever young Hand Cream
With Sea Buckthorn
Broad Spectrum Sunscreen SPF 40 PA+++
Supergoop
1 fl. oz./30 mL
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75936-128-02 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b3e7-a426-e053-dadaa90af4c2 | Forever Young Hand Cream Broad Spectrum SPF 40 |
| 75936-128-04 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b3e7-a426-e053-dadaa90af4c2 | Forever Young Hand Cream Broad Spectrum SPF 40 |
| 75936-128-06 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b3e7-a426-e053-dadaa90af4c2 | Forever Young Hand Cream Broad Spectrum SPF 40 |
| 75936-128-07 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b3e7-a426-e053-dadaa90af4c2 | Forever Young Hand Cream Broad Spectrum SPF 40 |
| 75936-128-08 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b3e7-a426-e053-dadaa90af4c2 | Forever Young Hand Cream Broad Spectrum SPF 40 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75936-128-01 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 4 mL in 1 BOTTLE | CREAM | 4 | 13 | |
| 75936-128-02 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 1 in 1 BOX | CREAM | 1 | 13 | |
| 75936-128-03 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 30 mL in 1 BOTTLE | CREAM | 30 | 13 | |
| 75936-128-04 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 1 in 1 BOX | CREAM | 1 | 13 | |
| 75936-128-05 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 300 mL in 1 BOTTLE | CREAM | 300 | 13 | |
| 75936-128-06 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 1 in 1 BOX | CREAM | 1 | 13 | |
| 75936-128-07 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 200 mL in 1 PACKAGE | CREAM | 200 | 13 | |
| 75936-128-08 | Forever Young Hand Broad Spectrum SPF 40Supergoop | 200 mL in 1 TUBE | CREAM | 200 | 13 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 75936-128 | FOREVER YOUNG HAND BROAD SPECTRUM SPF 40 SUPERGOOP (AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTOCRYLENE) CREAM [TAYLOR JAMES, LTD.] | 13 | Legacy NDC, 8 package rows | 20201113_ebda6c14-ae3c-4b83-8e1f-561e4f80e4de.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 3 | |
| HOMOSALATE | ACTIVE INGREDIENT | V06SV4M95S | 3 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 3 | |
| OCTOCRYLENE | ACTIVE INGREDIENT | 5A68WGF6WM | 3 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 3 | |
| HOMOSALATE | ACTIVE MOIETY | V06SV4M95S | 3 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 3 | |
| OCTOCRYLENE | ACTIVE MOIETY | 5A68WGF6WM | 3 | |
| ARGAN OIL | INACTIVE INGREDIENT | 4V59G5UW9X | 3 | |
| CARDAMOM OIL | INACTIVE INGREDIENT | JM0KJ091HZ | 3 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 3 | |
| CETYL ESTERS WAX | INACTIVE INGREDIENT | D072FFP9GU | 3 | |
| CHLORPHENESIN | INACTIVE INGREDIENT | I670DAL4SZ | 3 | |
| CITRAL | INACTIVE INGREDIENT | T7EU0O9VPP | 3 | |
| CLOVE OIL | INACTIVE INGREDIENT | 578389D6D0 | 3 | |
| CYMBOPOGON SCHOENANTHUS OIL | INACTIVE INGREDIENT | XE7K568ILO | 3 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | 3 | |
| DIISOPROPYL SEBACATE | INACTIVE INGREDIENT | J8T3X564IH | 3 | |
| EUCALYPTUS OIL | INACTIVE INGREDIENT | 2R04ONI662 | 3 | |
| GLUCOSE OXIDASE | INACTIVE INGREDIENT | 0T8392U5N1 | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 3 | |
| ISODECYL NEOPENTANOATE | INACTIVE INGREDIENT | W60VYE24XC | 3 | |
| ISODODECANE | INACTIVE INGREDIENT | A8289P68Y2 | 3 | |
| LACTOPEROXIDASE BOVINE | INACTIVE INGREDIENT | 01UIN5OC49 | 3 | |
| LAURYL LACTATE | INACTIVE INGREDIENT | G5SU0BFK7O | 3 | |
| LAVANDIN OIL | INACTIVE INGREDIENT | 9RES347CKG | 3 | |
| LIMONENE, (+)- | INACTIVE INGREDIENT | GFD7C86Q1W | 3 | |
| MAGNESIUM SULFATE | INACTIVE INGREDIENT | DE08037SAB | 3 | |
| MANDARIN OIL | INACTIVE INGREDIENT | NJO720F72R | 3 | |
| MEADOWFOAM SEED OIL | INACTIVE INGREDIENT | 412ZHA4T4Y | 3 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 3 | |
| NYLON-12 | INACTIVE INGREDIENT | 446U8J075B | 3 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 3 | |
| PLANTAGO LANCEOLATA LEAF | INACTIVE INGREDIENT | 2YWL9J7EE8 | 3 | |
| PROPANEDIOL | INACTIVE INGREDIENT | 5965N8W85T | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 75936-128 | 75936-128-01, 75936-128-02, 75936-128-07, 75936-128-03, 75936-128-04, 75936-128-05, 75936-128-06, 75936-128-08 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TROCHE / ORAL | 903.5 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | JELLY / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED PELLETS / ORAL | 0.01 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBMUCOSAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPRAY, METERED / NASAL | ADJ PH | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | GRANULE, FOR SUSPENSION / ORAL | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / ORAL | 84 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRATHECAL | ADJ PH | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET / ORAL | 56 mg | ||
| CETYL ESTERS WAX | CETYL ESTERS WAX | D072FFP9GU | CREAM / VAGINAL | 3 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL, METERED / TRANSDERMAL | 350 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, DELAYED RELEASE / ORAL | 4 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / PERIDURAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SUSPENSION / ORAL | 9 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 78.36 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT / TOPICAL | ADJ PH | ||
| LIMONENE, (+)- | LIMONENE, (+)- | GFD7C86Q1W | GEL / TOPICAL | 10 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRATHECAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SHAMPOO / TOPICAL | 3 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / TOPICAL | ADJ PH | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | PASTE / ORAL | 1050 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / VAGINAL | 20 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TROCHE / ORAL | 948 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION, AUGMENTED / TOPICAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRABURSAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPRAY / NASAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 136.55 mg | ||
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | DE08037SAB | TABLET, FILM COATED / ORAL | 14 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADERMAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / OPHTHALMIC | 6 mg | ||
| LIMONENE, (+)- | LIMONENE, (+)- | GFD7C86Q1W | LOTION / TOPICAL | 10 %v/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAVASCULAR | ADJ PH | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / TOPICAL | 3.27 %w/w | ||
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | DE08037SAB | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, DELAYED RELEASE / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | MOUTHWASH / BUCCAL | 2 mg/1ml | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-AMNIOTIC | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| CLOVE OIL | CLOVE OIL | 578389D6D0 | ELIXIR / ORAL | 0.42 mg/5ml | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, EXTENDED RELEASE / TRANSDERMAL | 0.85 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GEL / TOPICAL | 58 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b3ef2d95-313e-2488-e053-2995a90ace63 | ebda6c14-ae3c-4b83-8e1f-561e4f80e4de | 2020-11-12 | Warnings | b3ef2d95-313e-2488-e053-2995a90ace63 ebda6c14-ae3c-4b83-8e1f-561e4f80e4de |
Adverse event summaries are temporarily unavailable. Other product information remains available.